Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug-Drug Interaction Study.
Mar Drugs. 2024 Apr 16;22(4):178. doi: 10.3390/md22040178.
Mar Drugs. 2024.
PMID: 38667795
Free PMC article.
Clinical Trial.
Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug-Drug Interaction Study.
Moreno I, Hernández T, Calvo E, Fudio S, Kahatt C, Fernández C, Iglesias JL, Corral G, Pérez-Ramos L, Montilla L, Zeaiter A, Lubomirov R.
Moreno I, et al. Among authors: perez ramos l.
Pharmaceuticals (Basel). 2024 Jan 30;17(2):182. doi: 10.3390/ph17020182.
Pharmaceuticals (Basel). 2024.
PMID: 38399397
Free PMC article.
Item in Clipboard
A model-based head-to-head comparison of single-agent lurbinectedin in the pivotal ATLANTIS Study.
Fudio S, Pérez-Ramos L, Asín-Prieto E, Zeaiter A, Lubomirov R.
Fudio S, et al. Among authors: perez ramos l.
Front Oncol. 2023 Jun 15;13:1152371. doi: 10.3389/fonc.2023.1152371. eCollection 2023.
Front Oncol. 2023.
PMID: 37397388
Free PMC article.
Item in Clipboard
Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics.
Fudio S, Sellers A, Pérez Ramos L, Gil-Alberdi B, Zeaiter A, Urroz M, Carcas A, Lubomirov R.
Fudio S, et al. Among authors: perez ramos l.
Cancer Chemother Pharmacol. 2022 Oct;90(4):285-299. doi: 10.1007/s00280-022-04467-7. Epub 2022 Aug 27.
Cancer Chemother Pharmacol. 2022.
PMID: 36029310
Review.
Item in Clipboard
Cite
Cite